Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS) Meeting Abstract
| Authors: | Shitara, K.; Tabernero, J.; Dvorkin, M.; Mansoor, W.; Arkenau, H. T.; Prokharau, A.; Alsina, M.; Ghidini, M.; Faustino, C.; Gorbunova, V.; Zhavrid, E.; Nishikawa, K.; Hosokawa, A.; Ganea, D.; Yalcin, S.; Fujitani, K.; Beretta, G.; Winkler, R.; Doi, T.; Ilson, D. H. |
| Abstract Title: | Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS) |
| Meeting Title: | ESMO Asia Congress 2018 |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2018 Nov 23-25 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-11-01 |
| Start Page: | ix55 |
| Language: | English |
| ACCESSION: | WOS:000458082200221 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy432.027 |
| Notes: | Meeting Abstract: 175P -- Source: Wos |
